VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,593,000 | +356.5% | 154,186 | +212.0% | 0.07% | +305.9% |
| Q1 2018 | $787,000 | -90.7% | 49,418 | -87.6% | 0.02% | -90.7% |
| Q4 2017 | $8,428,000 | +19.3% | 398,305 | -2.5% | 0.18% | +29.1% |
| Q2 2017 | $7,065,000 | +97.9% | 408,397 | +26.2% | 0.14% | +62.1% |
| Q1 2017 | $3,570,000 | +48.6% | 323,652 | +95.5% | 0.09% | +2.4% |
| Q4 2016 | $2,403,000 | -42.2% | 165,521 | +4.7% | 0.08% | -28.6% |
| Q1 2016 | $4,157,000 | +174.2% | 158,050 | +1760.3% | 0.12% | +147.9% |
| Q3 2015 | $1,516,000 | +50.8% | 8,496 | +87.7% | 0.05% | +77.8% |
| Q2 2015 | $1,005,000 | -91.9% | 4,526 | -92.8% | 0.03% | -91.5% |
| Q1 2015 | $12,439,000 | +112.1% | 62,625 | +52.7% | 0.32% | +145.7% |
| Q4 2014 | $5,865,000 | -36.6% | 41,008 | -43.6% | 0.13% | -57.0% |
| Q2 2014 | $9,249,000 | -72.1% | 72,732 | -71.0% | 0.30% | -68.9% |
| Q1 2014 | $33,109,000 | +357.1% | 251,148 | +307.1% | 0.96% | +430.2% |
| Q4 2013 | $7,243,000 | -64.2% | 61,691 | -68.2% | 0.18% | -59.6% |
| Q3 2013 | $20,259,000 | +16.8% | 194,181 | -3.6% | 0.45% | -3.8% |
| Q2 2013 | $17,339,000 | – | 201,425 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |